
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Jubilant Therapeutics is a patient-focused biopharmaceutical company advancing potent and selective small molecule modulators to address specific unmet medical needs in oncology and autoimmune diseases. The companys leadership and scientific team are science-driven executives with global pharma background and experience in advancing innovative drug candidates into the clinic. Jubilant Therapeutics is headquartered in the U.S. with independent board and management, guided by globally renowned KOLs and SAB. Key Therapeutic Areas Oncology Auto-immune Disorders Portfolio Novel PAD4 inhibitors targeting auto-immune disorders Dual LSD1/HDAC6 inhibitors targeting cancer Novel small molecule PD-L1 inhibitors Novel brain penetrating PRMT5 inhibitors targeting cancer
Jubilant therapeutics inc operates in the Biotechnology industry.
Jubilant therapeutics inc's revenue is 11m - 100m
Jubilant therapeutics inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.